Real-world response and outcomes in NSCLC patients with EGFR exon 20 insertion mutations.

9098Background: There is currently no targeted therapy approved for patients with EGFR exon 20 insertion mutations (exon20ins) in NSCLC. Real world treatment outcome evidence for this rare populati...